Erasca Inc
Biotechnology
Healthcare
ERAS
283 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.79
52 week high
3.23
high
1.89
52 week low
0.00
low
1.75
growth
-38.75 %
previous Close
1.78
P/E ratio
market cap
442 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
-9.09 %
eps surprise
-2.39 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top